Add to ORKGA method of using a bioactive lysophospholipid (LL) as a biomarker for detecting the presence and recurrence of ovarian cancer. Subspecies of LL, such as lysophosphatidic acid (LPA), lysophosphatidylinositol (LPI), lysophosphatidylcholine (LPC), and lysosphingolipid sphinsosine-1-phosphate (S1P), are used alone or in conjunction to increase the specificity and sensitivity of the assay
Plasma levels of lysophospholipids were evaluated as potential biomarkers for colorectal cancer (CRC...
Lysophosphatidic acid (LPA) is a "bioactive" phospholipid able to generate growth factor-like activi...
Role of ether-linked lysophosphatidic acids in ovarian cancer cells Jun Lu, * Yi-jin Xiao, * Linnea ...
A method of using a bioactive lysophospholipid (LL) as a biomarker for detecting the presence and re...
OBJECTIVE: To determine whether lysophosphatidic acid (LPA) and other lysophospholipids (LPL) are us...
Ovarian cancer is a disease that affects a quarter of a million new women and causes over 140,000 de...
A method of detecting a cancer, such as ovarian cancer, in a test subject including (a) determining ...
As one of the important cancer hallmarks, metabolism reprogramming, including lipid metabolism alter...
Increased detection of plasma lysophosphatidic acid (LPA) has been proposed as a potential diagnosti...
By using colloidal gold as a hapten carrier, a kind of antibody against lysophosphatidic acid (LPA) ...
Lysophosphatidic acid (LPA) is the simplest form of lysophospholipid. Molecular species of LPA have ...
Ovarian cancer (OC) is the most common cause of death from gynecologic malignancies in women. The id...
Background: More than two-thirds of women who undergo surgery for suspected ovarian neoplasm do not ...
BACKGROUND:More than two-thirds of women who undergo surgery for suspected ovarian neoplasm do not h...
The history of biomarkers and ultrasonography dates back over more than 50 years. The present status...
Plasma levels of lysophospholipids were evaluated as potential biomarkers for colorectal cancer (CRC...
Lysophosphatidic acid (LPA) is a "bioactive" phospholipid able to generate growth factor-like activi...
Role of ether-linked lysophosphatidic acids in ovarian cancer cells Jun Lu, * Yi-jin Xiao, * Linnea ...
A method of using a bioactive lysophospholipid (LL) as a biomarker for detecting the presence and re...
OBJECTIVE: To determine whether lysophosphatidic acid (LPA) and other lysophospholipids (LPL) are us...
Ovarian cancer is a disease that affects a quarter of a million new women and causes over 140,000 de...
A method of detecting a cancer, such as ovarian cancer, in a test subject including (a) determining ...
As one of the important cancer hallmarks, metabolism reprogramming, including lipid metabolism alter...
Increased detection of plasma lysophosphatidic acid (LPA) has been proposed as a potential diagnosti...
By using colloidal gold as a hapten carrier, a kind of antibody against lysophosphatidic acid (LPA) ...
Lysophosphatidic acid (LPA) is the simplest form of lysophospholipid. Molecular species of LPA have ...
Ovarian cancer (OC) is the most common cause of death from gynecologic malignancies in women. The id...
Background: More than two-thirds of women who undergo surgery for suspected ovarian neoplasm do not ...
BACKGROUND:More than two-thirds of women who undergo surgery for suspected ovarian neoplasm do not h...
The history of biomarkers and ultrasonography dates back over more than 50 years. The present status...
Plasma levels of lysophospholipids were evaluated as potential biomarkers for colorectal cancer (CRC...
Lysophosphatidic acid (LPA) is a "bioactive" phospholipid able to generate growth factor-like activi...
Role of ether-linked lysophosphatidic acids in ovarian cancer cells Jun Lu, * Yi-jin Xiao, * Linnea ...